Heterogeneity and shifts in distribution of muscle weakness in myasthenia gravis
Open Access
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 29 (9) , 664-670
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Distinct representation of muscle weakness in QMG and MG-ADLThe Lancet Neurology, 2018
- Myasthenia Gravis Impairment IndexNeurology, 2017
- Myasthenia gravis: subgroup classification and therapeutic strategiesThe Lancet Neurology, 2015
- Current overview of myasthenia gravis and experience in ChinaNeuroimmunology and Neuroinflammation, 2014
- Myasthenia gravis: New therapeutic approaches based on pathophysiologyJournal of the Neurological Sciences, 2013
- Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityThe Lancet Neurology, 2009
- Treatment of ocular symptoms in myasthenia gravisNeurology, 2008
- Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndromeJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Muscles of a different 'color'Neurology, 1996
- Myasthenia Gravis, A Model of Organ-Specific Autoimmune DiseaseJournal of Autoimmunity, 1995